Establishment of induced pluripotent stem cells from aged mice using bone marrow-derived myeloid cells

Journal of Molecular Cell Biology

Volumn 3, Issue 2, 2011, Pages 91-98

  Cheng, Zhao ^a   Ito, Sachiko ^a   Nishio, Naomi ^a   Xiao, Hengyi ^b   Zhang, Rong ^a   Suzuki, Haruhiko ^a   Okawa, Yayoi ^c   Murohara, Toyoaki ^a   Isobe, Ken Ichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SICHUAN UNIVERSITY   (China)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

aged mouse; bone marrow myeloid cells; ChIP assay; gene expression; induced pluripotent stem cells; methylation

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL; ARTICLE; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CULTURE TECHNIQUE; CYTOLOGY; FEMALE; MALE; METABOLISM; MOUSE; PLURIPOTENT STEM CELL; TIME;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; CULTURE TECHNIQUES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INDUCED PLURIPOTENT STEM CELLS; MALE; MICE; MICE, INBRED C57BL; MYELOID CELLS; TIME FACTORS;

EID: 79953850339     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjq044     Document Type: Article

References (42)

1. Amoh, Y., Kanoh, M., Niiyama, S., et al. (2009). Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: an advantageous alternative to ES and iPS cells. J. Cell. Biochem. 107, 1016-1020.
2. Aoi, T., Yae, K., Nakagawa, M., et al. (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321, 699-702.
3. Chen, S.J., Chang, C.M., Tsai, S.K., et al. (2010). Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue. Stem Cells Dev. 19, 1757-1767.
4. Cho, H.J., Lee, C.S., Kwon, Y.W., et al. (2010). Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood 116, 386-395.
5. Choi, K.D., Yu, J., Smuga-Otto, K., et al. (2009). Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27, 559-567.
6. Eminli, S., Foudi, A., Stadtfeld, M., et al. (2009). Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat. Genet. 41, 968-976.
7. Feng, Q., Lu, S.J., Klimanskaya, I., et al. (2010). Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28, 704-712.
8. Fouse, S.D., Shen, Y., Pellegrini, M., et al. (2008). Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell 2, 160-169. (Pubitemid 351168712)
9. Hanna, J., Wernig, M., Markoulaki, S., et al. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920-1923.
10. Hanna, J., Markoulaki, S., Schorderet, P., et al. (2008). Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133, 250-264. (Pubitemid 351508307)
11. Hattori, N., Imao, Y., Nishino, K., et al. (2007). Epigenetic regulation of Nanog gene inembryonic stem and trophoblast stem cells. Genes Cells 12, 387-396. (Pubitemid 46359591)
12. Hong, H., Takahashi, K., Ichisaka, T., et al. (2009). Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460, 1132-1135.
13. Hwang, D.Y., Kim, D.S., and Kim, D.W. (2010). Human ES and iPS cells as cell sources for the treatment of Parkinson's disease: current state and problems. J. Cell. Biochem. 109, 292-301.
14. Inaba, K., Inaba, M., Romani, N., et al. (1992). Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/ macrophage colony-stimulating factor. J. Exp. Med. 176, 1693-1702.
15. Jaenisch, R., and Young, R. (2008). Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567-582. (Pubitemid 351253686)
16. Ji, J., Vijayaragavan, K., Bosse, M., et al. (2008). OP9 stroma augments survival of hematopoietic precursors and progenitors during hematopoietic differentiation from human embryonic stem cells. Stem Cells 26, 2485-2495.
17. Kim, J.B., Zaehres, H., Wu, G., et al. (2008). Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454, 646-650.
18. Kondo, Y., Shen, L., Cheng, A.S., et al. (2008). Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat. Genet. 40, 741-750. (Pubitemid 351748874)
19. Kunisato, A., Wakatsuki, M., Kodama, Y., et al. (2010). Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells. Stem Cells Dev. 19, 229-238.
20. Li, H., Collado, M., Villasante, A., et al. (2009). The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460, 1136-1139.
21. Liang, J., Wan, M., Zhang, Y., et al. (2008). Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol. 10, 731-739. (Pubitemid 351772939)
22. Loh, Y.H., Wu, Q., Chew, J.L., et al. (2006). The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38, 431-440.
23. Morita, S., Kojima, T., and Kitamura, T. (2000). Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7, 1063-1066. (Pubitemid 30398356)
24. Ohnuki, M., Takahashi, K., and Yamanaka, S. (2009). Generation and characterization of human induced pluripotent stem cells. Curr. Protoc. Stem Cell Biol. 9, 4A.2.1-4A.2.25.
25. Okabe, M., Ikawa, M., Kominami, K., et al. (1997). 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407, 313-319. (Pubitemid 27199450)
26. Okabe, M., Otsu, M., Ahn, D.H., et al. (2009). Definitive proof for direct reprogramming of hematopoietic cells to pluripotency. Blood 114, 1764-1767.
27. Seifinejad, A., Tabebordbar, M., Baharvand, H., et al. (2010). Progress and promise towards safe induced pluripotent stem cells for therapy. Stem Cell Rev. 6, 297-306.
28. Senju, S., Hirata, S., Matsuyoshi, H., et al. (2003). Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells. Blood 101, 3501-3508. (Pubitemid 36857934)
29. Senju, S., Haruta, M., Matsunaga, Y., et al. (2009). Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells 27, 1021-1031.
30. Shukla, A., Chaurasia, P., and Bhaumik, S.R. (2009). Histone methylation and ubiquitination with their cross-talk and roles in gene expression and stability. Cell Mol. Life Sci. 66, 1419-1433.
31. Stadtfeld, M., Maherali, N., Breault, D.T., et al. (2008). Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2, 230-240.
32. Sun, Z.W., and Allis, C.D. (2002). Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast. Nature 418, 104-108. (Pubitemid 34742580)
33. Sun, N., Longaker, M.T., and Wu, J.C. (2010). Human iPS cell-based therapy: considerations before clinical applications. Cell Cycle 9, 880-885.
34. Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. (Pubitemid 44233629)
35. Takahashi, K., Tanabe, K., Ohnuki, M., et al. (2007). Induction of pluripotent stemcells fromadult human fibroblasts by defined factors. Cell 131, 861-872. (Pubitemid 350138099)
36. Tay, Y., Zhang, J., Thomson, A.M., et al. (2008). MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455, 1124-1128.
37. Tenney, K., Gerber, M., Ilvarsonn, A., et al. (2006). Drosophila Rtf1 functions in histone methylation, gene expression, and notch signaling. Proc. Natl. Acad. Sci. USA 103, 11970-11974. (Pubitemid 44215795)
38. Vaissiere, T., Sawan, C., and Herceg, Z. (2008). Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat. Res. 659, 40-48.
39. VandenDriessche, T., Ivics, Z., Izsvak, Z., et al. (2009). Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells. Blood 114, 1461-1468.
40. Vodyanik, M.A., Bork, J.A., Thomson, J.A., et al. (2005). Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 105, 617-626. (Pubitemid 40070744)
41. Wernig, M., Meissner, A., Foreman, R., et al. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318-324. (Pubitemid 47080337)
42. Williams, R.L., Hilton, D.J., Pease, S., et al. (1988). Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336, 684-687. (Pubitemid 19007951)